Suppr超能文献

半乳糖凝集素-3血清水平有助于临床医生筛查涎腺肿瘤患者。

Galectin-3 Serum Levels Could Help Clinicians Screen for Salivary Gland Tumor Patients.

作者信息

Andisheh-Tadbir Azadeh, Mardani Maryam, Malekzadeh Mahyar, Amirbeigi Tafti Tayebe, Khademi Bijan

机构信息

Oral and Dental Disease Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):689-692. doi: 10.22034/APJCP.2018.19.3.689.

Abstract

Objective: To identify serum levels of galectin-3 in salivary gland cancer and healthy populations; a prospective analysis was performed on serum specimens from 105 patients with salivary gland cancer and 56 healthy persons. Methods: Enzyme-linked immunosorbent assay (ELISA) was used to measure levels of galectin-3 (GAL-3). Serum levels were compared between patients with salivary gland tumors and healthy control. A total of 105 patients were enrolled in the study (55 men, 50 women). Result: Mean age was 45.5 years. Thirty-nine patients with malignant and 66 cases with benign tumors were compared with 56 healthy participants with a mean age of 51.7. No statistically significant differences were observed when comparing GAL-3 serum levels between malignant and benign salivary gland tumor patients, but a statistically significant difference was found between case and control patients with p-values of 0.02. Serum levels of galectin-3 protein were elevated in patients with salivary gland cancer compared with the healthy population. Conclusion: The difference between benign and malignant tumor patients was significant, but revealed no clinic pathological characteristics in malignant tumors. To the best of the authors’ knowledge, this is the first time a study suggests that GAL-3 serum levels could help clinicians screen for salivary gland cancer.

摘要

目的

确定唾液腺癌患者和健康人群的血清半乳糖凝集素-3水平;对105例唾液腺癌患者和56名健康人的血清样本进行了前瞻性分析。方法:采用酶联免疫吸附测定法(ELISA)检测半乳糖凝集素-3(GAL-3)水平。比较唾液腺肿瘤患者和健康对照者的血清水平。共有105例患者纳入研究(55例男性,50例女性)。结果:平均年龄为45.5岁。将39例恶性肿瘤患者和66例良性肿瘤患者与56名平均年龄为51.7岁的健康参与者进行比较。比较恶性和良性唾液腺肿瘤患者的GAL-3血清水平时未观察到统计学上的显著差异,但病例组和对照组之间存在统计学上的显著差异,p值为0.02。与健康人群相比,唾液腺癌患者的半乳糖凝集素-3蛋白血清水平升高。结论:良性和恶性肿瘤患者之间存在显著差异,但在恶性肿瘤中未发现临床病理特征。据作者所知,这是首次有研究表明GAL-3血清水平可帮助临床医生筛查唾液腺癌。

相似文献

1
Galectin-3 Serum Levels Could Help Clinicians Screen for Salivary Gland Tumor Patients.
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):689-692. doi: 10.22034/APJCP.2018.19.3.689.
4
Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study.
Braz J Otorhinolaryngol. 2017 May-Jun;83(3):276-284. doi: 10.1016/j.bjorl.2016.03.013. Epub 2016 Apr 27.
6
Serum galectin-3 as a potential marker for gastric cancer.
Med Sci Monit. 2015 Mar 13;21:755-60. doi: 10.12659/MSM.892386.
8
Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
Thyroid. 2008 Jul;18(7):705-12. doi: 10.1089/thy.2007.0361.

引用本文的文献

1
A critical influence of HIF-1 on MMP-9 and Galectin-3 in oral lichen planus.
BMC Oral Health. 2024 Jun 29;24(1):756. doi: 10.1186/s12903-024-04457-6.
3
The Protective Effect of miR-27-3p on Ischemia-Reperfusion-Induced Myocardial Injury Depends on HIF-1α and Galectin-3.
J Cardiovasc Transl Res. 2022 Aug;15(4):772-785. doi: 10.1007/s12265-021-10203-y. Epub 2022 Feb 22.

本文引用的文献

2
VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.
PLoS One. 2013 Jun 17;8(6):e67029. doi: 10.1371/journal.pone.0067029. Print 2013.
3
Galectin-3: a possible complementary marker to the PSA blood test.
Oncotarget. 2013 Apr;4(4):542-9. doi: 10.18632/oncotarget.923.
5
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.
J Cancer Res Clin Oncol. 2012 Jun;138(6):1035-43. doi: 10.1007/s00432-012-1178-2. Epub 2012 Feb 25.
7
Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients.
Immunopharmacol Immunotoxicol. 2010 Mar;32(1):160-4. doi: 10.1080/08923970902936880.
8
Serum level of galectin-3 in human bladder cancer.
J Med Invest. 2008 Feb;55(1-2):127-32. doi: 10.2152/jmi.55.127.
10
Galectin-3 in apoptosis, a novel therapeutic target.
J Bioenerg Biomembr. 2007 Feb;39(1):79-84. doi: 10.1007/s10863-006-9063-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验